PMS2 and pachyonychia congenita: In a large prospective cohort of LS patients, the cumulative risk of PC by age 75 was highest for MLH1 carriers (RR 7.8), while no increased risk was observed for PMS2 carriers; however, data on PMS2 remain limited [142].